Corda Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
1,216
+17
+1% +$17.4K 0.09% 69
2026
Q1
$1.1M Hold
1,199
0.08% 74
2025
Q4
$1.29M Sell
1,199
-359
-23% -$343K 0.09% 75
2025
Q3
$1.19M Buy
1,558
+8
+0.5% +$5.95K 0.08% 78
2025
Q2
$1.21M Sell
1,550
-54
-3% -$42K 0.09% 70
2025
Q1
$1.32M Buy
1,604
+35
+2% +$29.1K 0.11% 63
2024
Q4
$1.21M Buy
1,569
+54
+4% +$44.7K 0.1% 67
2024
Q3
$1.34M Buy
1,515
+38
+3% +$34.2K 0.1% 63
2024
Q2
$1.34M Sell
1,477
-190
-11% -$152K 0.11% 61
2024
Q1
$1.3M Buy
+1,667
New +$1.19M 0.1% 60

Other funds holding LLY

Corda Investment Management's LLY Position: Q2 2026 in Review

Corda Investment Management increased its Eli Lilly (LLY) stake by 1.4% in Q2 2026, buying an estimated $17.4K and bringing the position to 1,216 shares worth $1.46M. The position accounts for 0.09% of the portfolio, ranked #69.

Corda Investment Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Corda Investment Management held 1,216 shares of Eli Lilly worth $1.46M as of Q2 2026.
  • Corda Investment Management bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
  • Eli Lilly made up 0.09% of Corda Investment Management's portfolio in Q2 2026, its #69 holding.
  • Corda Investment Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Corda Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.